THE SURGEON CHOOSES THE BEST PLAN.
RLES AI TESTS EVERY OPTION.

RLES AI® is a development and investment of MCD Technology Investments Inc. — built case by case with practising cataract and refractive surgeons, on a single conviction: the best outcome comes from AI precision serving the surgeon’s decision, never replacing it.

WHAT RLES AI IS

A clinical decision support platform for refractive laser eye surgery and cataract/RLE planning, delivered as a mobile interface on the surgeon’s phone: investigations or voice notes are uploaded there and signature-ready planning and screening reports come back in minutes. Eighteen capabilities cover the patient’s whole journey — from the first ectasia screen to the cataract surgery decades later — under one binding safety engine and one principle: the final clinical decision rests with the surgeon.

HOW IT IS BUILT

• Rule by rule, with practising surgeons: every clinical rule is taught, challenged and approved before it enters the engine
• Device truth only: nomograms and specifications come from manufacturers’ published tables and official instructions for use — never guessed
• Explainable throughout: every recommendation carries its rule, formula and literature
• Designed with the FDA’s Clinical Decision Support framework in mind; image-analysis-dependent modules are disabled in the US Edition pending regulatory submission

MEDICAL ADVISORY BOARD

RLES AI's clinical rule set is developed and refined in ongoing collaboration with practising ophthalmic surgeons. Advisors contribute clinical expertise to the development and validation of the platform's rules; they do not author individual patient reports, and the final clinical decision in every case rests with the treating surgeon.

MEDICAL ADVISORY BOARD

Antonio Méndez Noble, MD
Ophthalmologist — Cataract & Refractive Surgery
Medical Director, Vision Mendez, Tijuana, Baja California, Mexico
Past President — Baja California College of Ophthalmologists · Mexican Center of Cornea and Refractive Surgery · Mexican Society of Cataract and Refractive Surgery
Memberships — American Academy of Ophthalmology (AAO) · American Society of Cataract and Refractive Surgery (ASCRS) · European Society of Cataract and Refractive Surgery (ESCRS)
Clinical Advisor — contributes to the development and clinical validation of the RLES AI rule set, with particular focus on device nomogram validation across microkeratome and lenticule platforms, and real-world case validation in cataract and refractive surgery.
Profile ↗ · LinkedIn Profile ↗

MEDICAL ADVISORY BOARD

Fırat Helvacıoğlu, MD, FEBOS-CR
Professor of Ophthalmology & Chair, Department of Ophthalmology, Üsküdar University Faculty of Medicine
Cataract & Refractive Surgery · Veni Vidi Eye Clinic, İstanbul, Türkiye
Fellow of the European Board of Ophthalmology — Cataract & Refractive Surgery (FEBOS-CR)
Memberships — Turkish Ophthalmological Society (active member, Cataract & Refractive Surgery unit) · American Society of Cataract and Refractive Surgery (ASCRS) · European Society of Cataract and Refractive Surgery (ESCRS)
Clinical Advisor — contributes to the development and clinical validation of the RLES AI rule set, with particular focus on wavefront-guided ablation planning, corneal cross-linking protocols and keratoconus management.
Clinic profile ↗ · University profile ↗ · ORCID ↗ · 13 publications on PubMed ↗ · 28 publications · h-index 8 on Web of Science ↗

Selected publications

Tetikoğlu M, Yeter C, Helvacıoğlu F et al. Effect of Corneal Incision Enlargement on Surgically Induced Astigmatism in Biaxial Microincision Cataract Surgery. Turk J Ophthalmol. 2016;46(3):99-103. PMID: 27800270 ↗

Yüzbaşıoğlu E, Helvacıoğlu F et al. The results of cataract nigra cases operated with the mini-nuc technique. Int Ophthalmol. 2009;29(6):451-7. PMID: 18923815 ↗

MEDICAL ADVISORY BOARD

Ercüment Bozkurt, MD
Professor of Ophthalmology, Department of Ophthalmology, Bahçeşehir University Faculty of Medicine
Cataract, Cornea & Refractive Surgery · Batıgöz Eye Health Group, İstanbul, Türkiye
Memberships — American Academy of Ophthalmology (AAO) · American Society of Cataract and Refractive Surgery (ASCRS) · European Society of Cataract and Refractive Surgery (ESCRS) · Turkish Ophthalmological Society (Cataract & Refractive Surgery, Cornea and Glaucoma units)
Clinical Advisor — contributes to the development and clinical validation of the RLES AI rule set, with particular focus on corneal surgery, keratoconus management and cataract surgery.
Clinic profile ↗ · University profile ↗ · ORCID ↗ · 46 publications on PubMed ↗

Selected publications

Bozkurt E, Özgürhan EB, Akçay BIS et al. Refractive, Topographic, and Aberrometric Results at 2-Year Follow-Up for Accelerated Corneal Cross-Link for Progressive Keratoconus. J Ophthalmol. 2017;2017:5714372. PMID: 28197339 ↗

Kurt T, Özgürhan EB, … Bozkurt E, Taşkapılı M. Accelerated (18 mW/cm²) Corneal Cross-Linking for Progressive Keratoconus: 18-Month Results. J Ocul Pharmacol Ther. 2016;32(4):186-91. PMID: 27027668 ↗

Özgürhan EB, Çelik U, Bozkurt E, Demirok A. Evaluation of subbasal nerve morphology and corneal sensation after accelerated corneal collagen cross-linking treatment on keratoconus. Curr Eye Res. 2015;40(5):484-9. PMID: 24979260 ↗

Sezgin Akçay BI, Özgürhan EB, Bozkurt E et al. Evaluation of pachymetric measurements with Scheimpflug photography-based system and OCT pachymetry at different stages of keratoconus. J Ophthalmol. 2014;2014:719205. PMID: 25143828 ↗

Çelik U, Bozkurt E, Çelik B, Demirok A, Yılmaz OF. Pain, wound healing and refractive comparison of mechanical and transepithelial debridement in photorefractive keratectomy for myopia. Cont Lens Anterior Eye. 2014;37(6):420-6. PMID: 25081522 ↗

MEDICAL ADVISORY BOARD

Fevzi Şentürk, MD
Professor of Ophthalmology, İstanbul Medipol University Faculty of Medicine
Retina Diseases & Cataract Surgery · European Retina Eye Center, İstanbul, Türkiye
Memberships — Turkish Ophthalmological Society (active member of the Medical Retina, Surgical Retina and Electrodiagnostics units; board member and education representative of the Electrodiagnostics unit) · Ophthalmological Society of Turkic Republics · International Society for Clinical Electrophysiology of Vision (ISCEV)
Clinical Advisor — contributes to the development and clinical validation of the RLES AI rule set, with particular focus on cataract & IOL planning, retinal risk assessment in refractive lens exchange, and the upcoming Retina module.
Profile ↗ · University profile ↗ · ORCID ↗ · 27 publications on PubMed ↗

Selected publications

Şentürk F, Özdemir H, Karaçorlu M, Karaçorlu SA, Uysal Ö. Retinal sensitivity improvement after intravitreal triamcinolone acetonide injection for macular edema secondary to branch retinal vein occlusion. Indian J Ophthalmol. 2013;61(1):3-7. PMID: 23275213 ↗

Aydın R, Özsütçü M, … Şentürk F. The assessment of macular electrophysiology and macular morphology in patients with vitiligo. Int Ophthalmol. 2018;38(1):233-239. PMID: 28108905 ↗

Kılıçarslan O, … Şentürk F, Aras C. Bilateral Cystoid Macular Edema after COVID-19: 1 Year Follow Up. Ocul Immunol Inflamm. 2023;31(6):1236-1239. PMID: 36074579 ↗

MEDICAL ADVISORY BOARD

Hüseyin Cengiz, MD
Ophthalmologist — Cataract & Refractive Surgery
Vizyon Eye Hospital, Mersin, Türkiye
Memberships — Turkish Ophthalmological Society · European Society of Cataract and Refractive Surgery (ESCRS)
Clinical Advisor and Medical Editor of this website — contributes to the development and clinical validation of the RLES AI rule set, with particular focus on complication prevention and analysis, enhancement & retreatment planning and cataract surgery, and reviews the content published on rlesai.com for clinical accuracy.
Profile ↗ · LinkedIn Profile ↗

Advisors are listed with their explicit written consent. The board grows as the clinical pilot expands.

MEDICAL ADVISORY BOARD

Berrin Toksü, MD
Ophthalmologist — Cataract & Refractive Surgery
Medicana Hospital Eye Clinic, İstanbul, Türkiye
Memberships — Turkish Ophthalmological Society · European Society of Cataract and Refractive Surgery (ESCRS)
Clinical Advisor and Medical Editor of this website — contributes to the development and clinical validation of the RLES AI rule set, with particular focus on cataract and refractive surgical planning and real-world case validation, and reviews the content published on rlesai.com for clinical accuracy.
Profile ↗

MEDICAL ADVISORY BOARD

Alim Hüseynov, MD
Ophthalmologist — Cataract & Refractive Surgery
Department of Ophthalmology, Nişantaşı Hospital, İstanbul, Türkiye
Memberships — Turkish Ophthalmological Society
Clinical Advisor — contributes to the development and clinical validation of the RLES AI rule set, with particular focus on real-world case validation across refractive procedures.
Profile ↗

WHERE IT IS GOING

The full platform launches in November 2026. Until then, RLES AI runs in active clinical pilot with registered surgeons across multiple countries, in sixteen languages. For partnership, evaluation or press inquiries, use the information request form — a real person answers.